Skip to content

Advertisement

Articles

Page 32 of 32

  1. Content type: Original investigation

    Fibrates correct the typical lipid abnormalities of type 2 diabetes mellitus, yet no study, to date, has specifically set out to evaluate the role of fibrate therapy in preventing cardiovascular events in this...

    Authors:

    Citation: Cardiovascular Diabetology 2004 3:9

    Published on:

  2. Content type: Original investigation

    Hypertriglyceridemia in combination with low HDL cholesterol levels is a risk factor for cardiovascular disease. Our objective was to evaluate the efficacy of ciprofibrate for the treatment of this form of dys...

    Authors: Carlos A Aguilar-Salinas, Andréia Assis-Luores-Vale, Benjamín Stockins, Hector Mario Rengifo, José Dondici Filho, Abrahão Afiune Neto, Lísia Marcílio Rabelo, Kerginaldo Paulo Torres, José Egídio Paulo de Oliveira, Carlos Alberto Machado, Eliana Reyes, Victor Saavedra, Fernando Florenzano, Ma Victoria Hernández, Sergio Hernandez Jiménez, Erika Ramírez…

    Citation: Cardiovascular Diabetology 2004 3:8

    Published on:

  3. Content type: Original investigation

    Acute hyperglycaemia is an independent cardiovascular risk factor in Type 2 diabetes which may be mediated through increased oxidative damage to plasma low density lipoprotein, and in vitro, high glucose conce...

    Authors: Mike Sampson, Isabel Davies, Jelena Gavrilovic, Brendan Sussams, Jackie Brown, Sian Astley and David A Hughes

    Citation: Cardiovascular Diabetology 2004 3:7

    Published on:

  4. Content type: Original investigation

    Arterial proteoglycans are implicated in the pathogenesis of atherosclerosis by their ability to trap plasma lipoproteins in the arterial wall and by their influence on cellular migration, adhesion and prolife...

    Authors: Iris J Edwards, Janice D Wagner, Catherine A Vogl-Willis, Kenneth N Litwak and William T Cefalu

    Citation: Cardiovascular Diabetology 2004 3:6

    Published on:

  5. Content type: Case Report

    Severe obesity is associated with important morbidity and increased mortality. The successes of lifestyle modifications and drug therapy have been partial and mostly unsustained in reducing obesity and its com...

    Authors: Philippe Woods, Carmen Paquette, Julie Martin, Jean-Gaston Dumesnil, Picard Marceau, Simon Marceau, Simon Biron, Frédéric Hould, Odette Lescelleur, Stéphane Lebel and Paul Poirier

    Citation: Cardiovascular Diabetology 2004 3:5

    Published on:

  6. Content type: Original investigation

    Type 2 diabetes mellitus (DM-2) is one of the most prevalent chronic diseases of the aged and contributes to a significant amount of cardiovascular disease morbidity and mortality. Exercise training may be ben...

    Authors: Jonathan McGavock, Sandra Mandic, Richard Lewanczuk, Matthew Koller, Isabelle Vonder Muhll, Arthur Quinney, Dylan Taylor, Robert Welsh and Mark Haykowsky

    Citation: Cardiovascular Diabetology 2004 3:3

    Published on:

  7. Content type: Original investigation

    Microalbuminuria and subsequent progression to proteinuria and nephropathy is associated with increased oxidative stress, increased inflammatory cytokines and increased cardiovascular (CVD) risk. The common fu...

    Authors: Jeffrey W Stephens, Steven J Hurel, Jayshree Acharya and Steve E Humphries

    Citation: Cardiovascular Diabetology 2004 3:2

    Published on:

  8. Content type: Review

    Vascularization is an exciting and complex mechanism involving angiogenesis and arteriogenesis. The metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM) are associated with multiple metabolic toxicities...

    Authors: Melvin R Hayden and Suresh C Tyagi

    Citation: Cardiovascular Diabetology 2004 3:1

    Published on:

  9. Content type: Original investigation

    Impaired fibrinolysis is found in impaired glucose tolerance and type 2 diabetes, associated with components of the metabolic syndrome. There are no data concerning fibrinolysis in subjects with normal glucose...

    Authors: Mats CE Eliasson, Jan-Håkan Jansson, Bernt Lindahl and Birgitta Stegmayr

    Citation: Cardiovascular Diabetology 2003 2:19

    Published on:

  10. Content type: Original investigation

    Angiogenic therapy with vascular endothelial growth factor (VEGF) has been proposed as a treatment paradigm for patients suffering from an insufficiency of collateral vessels. Diabetes is associated with incre...

    Authors: Ariel Roguin, Samy Nitecki, Irit Rubinstein, Eviatar Nevo, Aaron Avivi, Nina S Levy, Zaid A Abassi, Edmond Sabo, Orit Lache, Meira Frank, Aaron Hoffman and Andrew P Levy

    Citation: Cardiovascular Diabetology 2003 2:18

    Published on:

  11. Content type: Original investigation

    Diabetic dyslipoproteinemia is characterized by hypertriglyceridemia, low HDL-cholesterol and often elevated LDL-cholesterol and is a strong risk factor for atherosclerosis. Adhesion molecule levels are elevat...

    Authors: Klaus Empen, Robert JA Frost, H Christian Geiss, Carsten Otto and Klaus G Parhofer

    Citation: Cardiovascular Diabetology 2003 2:17

    Published on:

  12. Content type: Original investigation

    Patients with diabetic cardiomyopathy have an impaired myocardial glucose handling and distal distribution of coronary atherosclerosis. Trimetazidine, an anti-ischemic metabolic agent, improves myocardial gluc...

    Authors: Giuseppe MC Rosano, Cristiana Vitale, Barbara Sposato, Giuseppe Mercuro and Massimo Fini

    Citation: Cardiovascular Diabetology 2003 2:16

    Published on:

  13. Content type: Original investigation

    An insertion/deletion polymorphism in the α2B-adrenoceptor (AR) has been associated with the risk for acute myocardial infarction (AMI) and sudden cardiac death. In this study we tested whether this polymorphism ...

    Authors: Amir Snapir, Mika Scheinin, Leif C Groop and Marju Orho-Melander

    Citation: Cardiovascular Diabetology 2003 2:15

    Published on:

  14. Content type: Original investigation

    Left ventricular hypertrophy (LVH) is a powerful independent risk factor for cardiovascular morbidity and mortality among hypertensive patients. Data regarding relationships between diabetes and LVH are contro...

    Authors: Alexander Tenenbaum, Enrique Z Fisman, Ehud Schwammenthal, Yehuda Adler, Michal Benderly, Michael Motro and Joseph Shemesh

    Citation: Cardiovascular Diabetology 2003 2:14

    Published on:

  15. Content type: Original investigation

    Even mild hyperglycemia is associated with future acute and chronic complications. Nevertheless, many cases of diabetes in the community go unrecognized. The aim of the study was to determine if national elect...

    Authors: Shlomo Vinker, Yaacov Fogelman, Asher Elhayany, Sasson Nakar and Ernesto Kahan

    Citation: Cardiovascular Diabetology 2003 2:13

    Published on:

  16. Content type: Original investigation

    More than seventeen million Americans are afflicted with diabetes and these people have four times the rate of coronary heart disease (CHD) as non-diabetics. Furthermore, diabetic women have a 3.8 fold greater...

    Authors: Hillary A Tuttle, Grace Davis-Gorman, Steven Goldman, Jack G Copeland and Paul F McDonagh

    Citation: Cardiovascular Diabetology 2003 2:12

    Published on:

  17. Content type: Hypothesis

    The impressive correlation between cardiovascular disease and glucose metabolism alterations has raised the likelihood that atherosclerosis and type 2 diabetes may share common antecedents. Inflammation is eme...

    Authors: Enrique Z Fisman, Michael Motro and Alexander Tenenbaum

    Citation: Cardiovascular Diabetology 2003 2:11

    Published on:

  18. Content type: Original investigation

    Recently a new automatic device that measures brachial-ankle pulse wave velocity using an oscillometric method has been developed. However, the practical significance of brachial-ankle pulse wave velocity meas...

    Authors: Osamu Ogawa, Tomio Onuma, Sayaka Kubo, Naomi Mitsuhashi, Chie Muramatsu and Ryuzo Kawamori

    Citation: Cardiovascular Diabetology 2003 2:10

    Published on:

  19. Content type: Original investigation

    A C825T polymorphism was recently identified in the gene encoding the β3 subunit of heterotrimeric G-proteins (GNB3). The T-allele is significantly associated with essential hypertension and obesity. In order to ...

    Authors: Jens Nürnberger, Sandra Dammer, Thomas Philipp, Rene R Wenzel and Rafael F Schäfers

    Citation: Cardiovascular Diabetology 2003 2:7

    Published on:

  20. Content type: Original investigation

    Using the streptozotocin-induced diabetic rat model, we have recently showed that the expression and function of β1-adrenoreceptor were decreased in the diabetic rat heart. However, the effect of diabetes on expr...

    Authors: U Deniz Dinçer, Şahika Güner, Aydin Tay, Ebru Arioğlu, Atilay Taşdelen, Sait Aşlamaci and Keshore R Bidasee

    Citation: Cardiovascular Diabetology 2003 2:6

    Published on:

  21. Content type: Original investigation

    Interleukin 8 (IL-8) is a cytokine with atherogenic properties. In vitro studies revealed that it is produced and secreted by human adipocytes. We recently reported that plasma IL-8 is increased in obese subje...

    Authors: Marek Straczkowski, Irina Kowalska, Agnieszka Nikolajuk, Stella Dzienis-Straczkowska, Malgorzata Szelachowska and Ida Kinalska

    Citation: Cardiovascular Diabetology 2003 2:5

    Published on:

  22. Content type: Review

    The metabolic syndrome is a highly prevalent clinical entity. The recent Adult Treatment Panel (ATP III) guidelines have called specific attention to the importance of targeting the cardiovascular risk factors...

    Authors: Alexander Tenenbaum, Enrique Z Fisman and Michael Motro

    Citation: Cardiovascular Diabetology 2003 2:4

    Published on:

  23. Content type: Original investigation

    Coronary plaque rupture may result from localised over expression of matrix metalloproteinases (MMPs) within the plaque by infiltrating monocyte – macrophages. As MMP expression can be promoted by the modified...

    Authors: Mark D Baugh, Jelena Gavrilovic, Isabel R Davies, David A Hughes and Mike J Sampson

    Citation: Cardiovascular Diabetology 2003 2:3

    Published on:

  24. Content type: Hypothesis

    Cardiovascular disease accounts for at least 85 percent of deaths for those patients with type 2 diabetes mellitus (T2DM). Additionally, 75 percent of these deaths are due to ischemic heart disease.

    Authors: Melvin R Hayden and Suresh C Tyagi

    Citation: Cardiovascular Diabetology 2003 2:2

    Published on:

  25. Content type: Review

    Our aim is to summarize and discuss the recent literature linking diabetes mellitus with heart failure, and to address the issue of the optimal treatment for diabetic patients with heart failure.

    Authors: Christophe Bauters, Nicolas Lamblin, Eugène P Mc Fadden, Eric Van Belle, Alain Millaire and Pascal de Groote

    Citation: Cardiovascular Diabetology 2003 2:1

    Published on:

  26. Content type: Original investigation

    There is little data on the relationship between novel cardiovascular risk factors and silent coronary artery disease (CAD) in diabetic patients. We investigated whether Lipoprotein(a), homocysteine and apolip...

    Authors: Carmine Gazzaruso, Adriana Garzaniti, Stefano Giordanetti, Colomba Falcone and Pietro Fratino

    Citation: Cardiovascular Diabetology 2002 1:5

    Published on:

  27. Content type: Original investigation

    The increase in the prevalence of insulin resistance-related metabolic syndrome, a disorder that greatly increases the risk of diabetes, heart attack and stroke, is alarming. One of the most frequent and early...

    Authors: Radka Lichnovská, Simona Gwozdziewiczová and Jirí Hrebícek

    Citation: Cardiovascular Diabetology 2002 1:4

    Published on:

  28. Content type: Review

    Metabolic syndrome, insulin resistance, prediabetes, and overt type 2 diabetes mellitus are associated with an accelerated atherosclerosis (atheroscleropathy). This quartet is also associated with multiple met...

    Authors: Melvin R Hayden and Suresh C Tyagi

    Citation: Cardiovascular Diabetology 2002 1:3

    Published on:

  29. Content type: Commentary

    The RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) study is a multinational, double-blind, randomized, placebo controlled trial which was recently published. It was aimed ...

    Authors: Enrique Z Fisman, Alexander Tenenbaum and Michael Motro

    Citation: Cardiovascular Diabetology 2002 1:2

    Published on:

journal logo

Annual Journal Metrics

Advertisement